{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:01:45Z","timestamp":1792800105502,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation for Medical Research at \u00d6rebro University Hospital, \u00d6rebro, Sweden","award":["2018"],"award-info":[{"award-number":["2018"]}],"id":[{"id":"https:\/\/ror.org\/02m62qy71","id-type":"ROR","asserted-by":"crossref"}]},{"name":"\u00d6rebro County Council Research Committee,  \u00d6rebro University Hospital, \u00d6rebro, Sweden","award":["2020"],"award-info":[{"award-number":["2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Four new variants of\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      (nvCTs), detected in several countries, cause false-negative or equivocal results using the Aptima Combo 2 assay (AC2; Hologic). We evaluated the clinical sensitivity and specificity, as well as the analytical inclusivity and exclusivity of the updated AC2 for the detection of CT and\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      (NG) on the automated Panther system (Hologic).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined 1004 clinical AC2 samples and 225 analytical samples spiked with phenotypically and\/or genetically diverse NG and CT strains, and other potentially cross-reacting microbial species. The clinical AC2 samples included CT wild type (WT)-positive (n\u2009=\u2009488), all four described AC2 diagnostic-escape nvCTs (n\u2009=\u2009170), NG-positive (n\u2009=\u2009214), and CT\/NG-negative (n\u2009=\u2009202) specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All nvCT-positive samples (100%) and 486 (99.6%) of the CT WT-positive samples were positive in the updated AC2. All NG-positive, CT\/NG-negative,\n                      <jats:italic>Trichomonas vaginalis<\/jats:italic>\n                      (TV)-positive, bacterial vaginosis-positive, and\n                      <jats:italic>Candida<\/jats:italic>\n                      -positive AC2 specimens gave correct results. The clinical sensitivity and specificity of the updated AC2 for CT detection was 99.7 and 100%, respectively, and for NG detection was 100% for both. Examining spiked samples, the analytical inclusivity and exclusivity were 100%, i.e., in clinically relevant concentrations of spiked microbe.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The updated AC2, including two CT targets and one NG target, showed a high sensitivity, specificity, inclusivity and exclusivity for the detection of CT WT, nvCTs, and NG. The updated AC2 on the fully automated Panther system offers a simple, rapid, high-throughput, sensitive, and specific diagnosis of CT and NG, which can easily be combined with detection of\n                      <jats:italic>Mycoplasma genitalium<\/jats:italic>\n                      and TV\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05148-7","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T10:03:47Z","timestamp":1592301827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-2081","authenticated-orcid":false,"given":"Magnus","family":"Unemo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronza","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirja","family":"Puolakkainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Westh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisu","family":"Rantakokko-Jalava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Thilesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Boiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham T.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"5148_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548\u201362P.","journal-title":"Bull World Health Organ"},{"key":"5148_CR2","unstructured":"European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx (Accessed: May 13, 2020)."},{"key":"5148_CR3","doi-asserted-by":"publisher","unstructured":"Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. Background review for the '2015 European guideline on the management of Chlamydia trachomatis infections'. Int J STD AIDS. 2015;0956462415618838. https:\/\/doi.org\/10.1177\/0956462415618838.","DOI":"10.1177\/0956462415618838"},{"issue":"11","key":"5148_CR4","doi-asserted-by":"publisher","DOI":"10.2807\/esw.11.45.03076-en","volume":"11","author":"T Ripa","year":"2006","unstructured":"Ripa T, Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill. 2006;11(11):E061109.2. https:\/\/doi.org\/10.2807\/esw.11.45.03076-en.","journal-title":"Euro Surveill."},{"key":"5148_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QCO.0b013e32834204d5","volume":"24","author":"M Unemo","year":"2011","unstructured":"Unemo M, Clarke IN. The Swedish new variant of Chlamydia trachomatis. Curr Opin Infect Dis. 2011;24:62\u20139.","journal-title":"Curr Opin Infect Dis"},{"key":"5148_CR6","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3201\/eid1409.080153","volume":"14","author":"B Herrmann","year":"2008","unstructured":"Herrmann B, T\u00f6rner A, Low N, Klint M, Nilsson A, Velicko I, et al. Emergence and spread of Chlamydia trachomatis variant, Sweden. Emerg Infect Dis. 2008;14:1462\u20135.","journal-title":"Emerg Infect Dis"},{"key":"5148_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1101\/gr.212647.116","volume":"27","author":"J Hadfield","year":"2017","unstructured":"Hadfield J, Harris SR, Seth-Smith HMB, Parmar S, Andersson P, Giffard PM, et al. Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion. Genome Res. 2017;27:1220\u20139.","journal-title":"Genome Res"},{"key":"5148_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/ng.2214","volume":"44","author":"SR Harris","year":"2012","unstructured":"Harris SR, Clarke IN, Seth-Smith HM, Solomon AW, Cutcliffe LT, Marsh P, et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet. 2012;44:413\u20139.","journal-title":"Nat Genet"},{"key":"5148_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/0956462419898982","volume":"31","author":"MF Silveira","year":"2020","unstructured":"Silveira MF, Bruni MP, Stauffert D, Golparian D, Unemo M. Prevalence and risk factors associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium among women in Pelotas, Southern Brazil. Int J STD AIDS. 2020;31:432\u20139.","journal-title":"Int J STD AIDS"},{"key":"5148_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/apm.12975","volume":"127","author":"I Boiko","year":"2019","unstructured":"Boiko I, Golparian D, Krynytska I, Unemo M. High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine. APMIS. 2019;127:627\u201334.","journal-title":"APMIS"},{"key":"5148_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1309\/AJCPFQ25SQVZAWHZ","volume":"141","author":"A Cheng","year":"2014","unstructured":"Cheng A, Kirby JE. Evaluation of the Hologic gen-probe PANTHER, APTIMA combo 2 assay in a tertiary care teaching hospital. Am J Clin Pathol. 2014;141:397\u2013403.","journal-title":"Am J Clin Pathol"},{"key":"5148_CR12","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1128\/JCM.42.7.3089-3093.2004","volume":"42","author":"B Boyadzhyan","year":"2004","unstructured":"Boyadzhyan B, Yashina T, Yatabe JH, Patnaik M, Hill CS. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2004;42:3089\u201393.","journal-title":"J Clin Microbiol"},{"key":"5148_CR13","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1128\/JCM.01217-11","volume":"49","author":"SN Tabrizi","year":"2011","unstructured":"Tabrizi SN, Unemo M, Limnios AE, Hogan TR, Hjelmevoll SO, Garland SM, et al. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol. 2011;49:3610\u20135.","journal-title":"J Clin Microbiol"},{"key":"5148_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ophtha.2014.08.038","volume":"122","author":"RP Kowalski","year":"2015","unstructured":"Kowalski RP, Karenchak LM, Raju LV, Ismail N. The verification of nucleic acid amplification testing (gen-probe Aptima assay) for Chlamydia trachomatis from ocular samples. Ophthalmology. 2015;122:244\u20137.","journal-title":"Ophthalmology."},{"key":"5148_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/OLQ.0b013e3182787e45","volume":"40","author":"D Golparian","year":"2013","unstructured":"Golparian D, Tabrizi SN, Unemo M. Analytical specificity and sensitivity of the APTIMA Combo 2 and APTIMA GC assays for detection of commensal Neisseria species and Neisseria gonorrhoeae on the Gen-Probe Panther instrument. Sex Transm Dis. 2013;40:175\u20138.","journal-title":"Sex Transm Dis"},{"key":"5148_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/OLQ.0000000000000627","volume":"44","author":"CC Bristow","year":"2017","unstructured":"Bristow CC, McGrath MR, Cohen AC, Anderson LA, Gordon KK, Klausner JD. Comparative evaluation of two nucleic acid amplification tests for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae at extragenital sites. Sex Transm Dis. 2017;44:398\u2013400.","journal-title":"Sex Transm Dis"},{"key":"5148_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/apm.12430","volume":"123","author":"T Rumyantseva","year":"2015","unstructured":"Rumyantseva T, Golparian D, Nilsson CS, Johansson E, Falk M, Fredlund H, et al. Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis. APMIS. 2015;123:879\u201386.","journal-title":"APMIS."},{"issue":"22","key":"5148_CR18","doi-asserted-by":"publisher","first-page":"1900298","DOI":"10.2807\/1560-7917.ES.2019.24.22.1900298","volume":"24","author":"K Rantakokko-Jalava","year":"2019","unstructured":"Rantakokko-Jalava K, Hokynar K, Hieta N, Keskitalo A, Jokela P, Muotiala A, et al. Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019. Euro Surveill. 2019;24(22):1900298 https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.22.1900298. PMID: 31164192.","journal-title":"Euro Surveill"},{"issue":"8","key":"5148_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/microorganisms7080227","volume":"7","author":"K Hokynar","year":"2019","unstructured":"Hokynar K, Rantakokko-Jalava K, Hakanen A, Havana M, Mannonen L, Jokela P, et al. The Finnish new variant of Chlamydia trachomatis with a single nucleotide polymorphism in the 23S rRNA target escapes detection by the Aptima Combo 2 test. Microorganisms. 2019;7(8):227. https:\/\/doi.org\/10.3390\/microorganisms7080227.","journal-title":"Microorganisms."},{"key":"5148_CR20","doi-asserted-by":"crossref","unstructured":"Unemo M, Hansen M, Hadad R, Lindroth Y, Fredlund H, Puolakkainen M, et al. Finnish new variant of Chlamydia trachomatis escaping detection in the Aptima Combo 2 assay also present in \u00d6rebro County, Sweden, May 2019. Euro Surveill. 2019;24(26) https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.26.1900370 PMID: 31266590.","DOI":"10.2807\/1560-7917.ES.2019.24.26.1900370"},{"key":"5148_CR21","doi-asserted-by":"crossref","unstructured":"Johansen TB, Kl\u00f8vstad H, Rykkvin R, Herrfurth-Erichsen EB, Sorthe J, Nj\u00f8lstad G, et al. The 'Finnish new variant of Chlamydia trachomatis' escaping detection in the Aptima Combo 2 assay is widespread across Norway, June to August 2019. Euro Surveill. 2019;24(42) https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.42.1900592 PMID: 31640843.","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900592"},{"key":"5148_CR22","doi-asserted-by":"crossref","unstructured":"Unemo M, Getman D, Hadad R, Cole M, Thomson N, Puolakkainen M, et al. Letter to the editor: Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019. Euro Surveill. 2019;24(24) https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.24.1900354 PMID: 31213219.","DOI":"10.2807\/1560-7917.ES.2019.24.24.1900354"},{"issue":"5","key":"5148_CR23","doi-asserted-by":"publisher","first-page":"2000038","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000038","volume":"25","author":"B Weinbaum","year":"2020","unstructured":"Weinbaum B, Williams A, Hadad R, Vinluan B, Puolakkainen M, Unemo M, Getman D. Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019. Euro Surveill. 2020;25(5):2000038. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.5.2000038.","journal-title":"Euro Surveill"},{"key":"5148_CR24","doi-asserted-by":"publisher","unstructured":"Hadad R, Jensen JS, Westh H, Gr\u00f8nbaek I, Schwartz LJ, Nielsen L, et al. A Chlamydia trachomatis 23S rRNA G1523A variant escaping detection in the Aptima Combo 2 assay (Hologic) was widespread across Denmark in July\u2013September 2019 [published online ahead of print, 2020 Mar 23]. APMIS. 2020. https:\/\/doi.org\/10.1111\/apm.13043.","DOI":"10.1111\/apm.13043"},{"key":"5148_CR25","doi-asserted-by":"crossref","unstructured":"Roberts DJ, Davis GS, Cole MJ, Naik D, Maru H, Woodford N, et al. Prevalence of new variants of Chlamydia trachomatis escaping detection by the Aptima Combo 2 assay, England, June to August 2019. Euro Surveill. 2019;24(38) https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2019.24.38.1900557 PMID: 31552817..","DOI":"10.2807\/1560-7917.ES.2019.24.38.1900557"},{"key":"5148_CR26","volume-title":"Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT\/NG assay (Hologic) in the EU\/EEA","author":"ECDC","year":"2019","unstructured":"ECDC. Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT\/NG assay (Hologic) in the EU\/EEA. Stockholm: European Centre for Disease Prevention and Control; 2019. 17.06."},{"key":"5148_CR27","unstructured":"Getman D. Mechanism of F-nvCT effect on AC2 performance, design and validation of F-nvCT surveillance IUO assay. IUSTI 2019 European congress, 5\u20137 September 2019, Tallinn, Estonia.."},{"key":"5148_CR28","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/jac\/dkw288","volume":"71","author":"M Unemo","year":"2016","unstructured":"Unemo M, Golparian D, S\u00e1nchez-Bus\u00f3 L, Grad Y, Jacobsson S, Ohnishi M, et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother. 2016;71:3096\u2013108.","journal-title":"J Antimicrob Chemother"},{"key":"5148_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/apm.12902","volume":"126","author":"S Jacobsson","year":"2018","unstructured":"Jacobsson S, Boiko I, Golparian D, Blondeel K, Kiarie J, Toskin I, et al. WHO laboratory validation of Xpert CT\/NG and Xpert TV on the GeneXpert system verifies high performances. APMIS. 2018;126:907\u201312.","journal-title":"APMIS."},{"key":"5148_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2340\/00015555-2314","volume":"96","author":"M Fr\u00f8lund","year":"2016","unstructured":"Fr\u00f8lund M, Lidbrink P, Wikstr\u00f6m A, Cowan S, Ahrens P, Jensen JS. Urethritis-associated pathogens in urine from men with non-gonococcal urethritis: a case-control study. Acta Derm Venereol. 2016;96:689\u201394.","journal-title":"Acta Derm Venereol"},{"key":"5148_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/sextrans-2016-052950","volume":"93","author":"D Priest","year":"2017","unstructured":"Priest D, Ong JJ, Chow EPF, Tabrizi S, Phillips S, Bissessor M. Neisseria gonorrhoeae DNA bacterial load in men with symptomatic and asymptomatic gonococcal urethritis. Sex Transm Infect. 2017;93:478\u201381.","journal-title":"Sex Transm Infect"},{"key":"5148_CR32","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1128\/JCM.01186-16","volume":"54","author":"EP Chow","year":"2016","unstructured":"Chow EP, Tabrizi SN, Phillips S, Lee D, Bradshaw CS, Chen MY, et al. Neisseria gonorrhoeae bacterial DNA load in the pharynges and saliva of men who have sex with men. J Clin Microbiol. 2016;54:2485\u201390.","journal-title":"J Clin Microbiol"},{"issue":"Pt 5","key":"5148_CR33","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1099\/mic.0.036830-0","volume":"156","author":"M Unemo","year":"2010","unstructured":"Unemo M, Seth-Smith HMB, Cutcliffe LT, Skilton RJ, Barlow D, Goulding D, et al. The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology. 2010;156(Pt 5):1394\u2013404.","journal-title":"Microbiology."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05148-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05148-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05148-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T19:10:04Z","timestamp":1623784204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05148-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5148"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05148-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All examined clinical AC2 samples were collected in routine diagnostics (standard care), and no patient identification information was available in the present study. Accordingly, no ethical approval was required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}